The Valley Desk

ArticleBiochemical and biophysical research communicationsPublished

Dual kinase inhibitor for EGFR mutants and ErbB2 limit breast cancer

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Biochemical and biophysical research communications
Published
Subject terms
Humans; Carcinoma, Non-Small-Cell Lung; Breast Neoplasms; Lung Neoplasms; Acrylamides; Aniline Compounds; Pyrimidines; Indoles; Antineoplastic Agents; Protein Kinase Inhibitors; Drug Resistance, Neoplasm; Mutation
PubMed ID
36791497
Added to directory
Source checked

Report a correction or request removal